← FDA ENFORCEMENT
D-0208-2025Class III

Appco Pharma LLC

Recalling firm
Appco Pharma LLC
Product type
Drug
Status
Completed
Report date
2025-01-29
Distribution
Nationwide USA.
Firm state
NJ
Product quantity
1380 bottles
Initiated by
Voluntary: Firm initiated
Reason for recall

Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet

Product description

Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, NDC 43598-943-90.

Code / lot info

Lot #: 2402101UR, Exp 02/28/2027

Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.